March 1 (Reuters) - Orexo AB
* Orexo commences patent infringement litigation against Actavis for their generic versions of Suboxone® and Subutex® tablets in the U.S.
* Orexo alleges that Actavis’s generic versions of Suboxone and Subutex tablets infringe Orexo’s US Patent No. 8,454,996 (the ‘996 patent) Source text for Eikon: Further company coverage: (Stockholm Newsroom)
Our Standards: The Thomson Reuters Trust Principles.